Douglas E. Brough

Corporate Officer/Principal presso PRECIGEN, INC.

69 anni

Consumer Services

Health Technology

Profilo

Douglas E.
Brough is currently the Senior Vice President & Head-Research at Precigen, Inc. Previously, he worked as the Chief Scientific Officer at GenVec, Inc. from 2013 to 2017.
Dr. Brough holds a doctorate degree from Rutgers State University of New Jersey and Robert Wood Johnson Medical School.
He also has a graduate degree from Idaho State University and an undergraduate degree from Purdue University.

Posizioni attive di Douglas E. Brough

Società	Posizione	Inizio
PRECIGEN, INC.	Corporate Officer/Principal	-

Tutte le posizioni attive di Douglas E. Brough

Precedenti posizioni note di Douglas E. Brough

Società	Posizione	Fine
GENVEC INC	Chief Tech/Sci/R&D Officer	16/06/2017

Vedi nel dettaglio l'esperienza di Douglas E. Brough

Formazione di Douglas E. Brough

Rutgers State University of New Jersey	Doctorate Degree
Idaho State University	Graduate Degree
Purdue University	Undergraduate Degree
Robert Wood Johnson Medical School	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Douglas E. Brough

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
PRECIGEN, INC.	Health Technology

Aziende private	1
GenVec, Inc. GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD.	Health Technology